financetom
Business
financetom
/
Business
/
Argan Fiscal Q1 EPS, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Argan Fiscal Q1 EPS, Revenue Increase
Jun 4, 2025 1:38 PM

04:14 PM EDT, 06/04/2025 (MT Newswires) -- Argan (AGX) reported fiscal Q1 earnings Wednesday of $1.60 per diluted share, up from $0.58 a year earlier.

One analyst polled by FactSet expected $1.07.

Revenue for the quarter ended April 30 was $193.7 million, up from $157.7 million a year earlier.

Two analysts surveyed by FactSet expected $193.8 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Norovirus Vaccine Trial Placed on Hold by FDA After Adverse Event
Moderna Norovirus Vaccine Trial Placed on Hold by FDA After Adverse Event
Feb 14, 2025
03:45 PM EST, 02/14/2025 (MT Newswires) -- Moderna ( MRNA ) said Friday its trial for a trivalent vaccine against norovirus is currently on hold by the US Food and Drug Administration after a single adverse event report of a close of Guillain-Barre syndrome. Investigation of the adverse event is currently underway, according to the company. Moderna ( MRNA )...
-- Primaris REIT Brief: Keeps Sector Perform, Target Edges Up To C$17.25 From $17 On
-- Primaris REIT Brief: Keeps Sector Perform, Target Edges Up To C$17.25 From $17 On "Strong" Q4 Results and Outlook, But Says "Macro Volatility Looms in the Background"
Feb 14, 2025
03:35 PM EST, 02/14/2025 (MT Newswires) -- Price: 15.35, Change: +0.64, Percent Change: +4.35 ...
Sector Update: Consumer
Sector Update: Consumer
Feb 14, 2025
03:31 PM EST, 02/14/2025 (MT Newswires) -- Consumer stocks were lower late Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) shedding 0.9% and the Consumer Discretionary Select Sector SPDR Fund (XLY) easing 0.1%. In corporate news, Uber ( UBER ) launched a seven-figure advertising campaign to generate support for the efforts to convince state regulators to lower...
Corbus Pharmaceuticals Reports Positive Data From Cancer Drug Trial -- Shares Slump
Corbus Pharmaceuticals Reports Positive Data From Cancer Drug Trial -- Shares Slump
Feb 14, 2025
03:32 PM EST, 02/14/2025 (MT Newswires) -- Corbus Pharmaceuticals ( CRBP ) shares slumped 10% in recent trading Friday despite reporting what it described as encouraging data from the Western clinical trial of its CRB-701 anti-body drug conjugate. A total of 26 patients with metastatic urothelial cancer and other solid tumors associated with Nectin-4 expression were evaluable at December 2024...
Copyright 2023-2026 - www.financetom.com All Rights Reserved